Consumers in Ontario will have to wait until April 1, 2019 to buy legal cannabis in adult-use shops as the provincial government outlines its rollout of the drug distribution.

After weeks of speculation, on Monday (August 13) the Ontario government confirmed its plan for the sale of adult-use cannabis in the province through private retailers.


The recently elected Premier Doug Ford will scrap the system put in place by the previous Ontario administration, in favour of an open system with private retailers in mind. However the province will only have online-sales available for consumers after the legalization of cannabis on October 17.

“We will be ready to put in place a safe, legal system for cannabis retail that will protect consumers,” Minister of Finance Vic Fedeli said. The minister added added the government has no plans to be in the business of operating a network of cannabis shops in Ontario.

A report from Marijuana Business Daily indicated the Ontario system is expected to see up to 500 retail licenses by the spring of 2019.

The government announced the introduction of an approving seal for “legitimate retailers” carrying product from licensed producers (LPs) only.

This decision from the Ontario government represents yet another delay for cannabis consumers in the province to gain legal retail options to purchase the drug.

Following the approval of Bill C-45 in the House of Commons and the Senate, Canadian Prime Minister Justin Trudeau confirmed the enactment of the bill was set in October, to accommodate the needs from the provinces to properly set up their models.

Municipalities in Ontario will be given what the provincial government is calling a “one-time window” to decide whether or not they will allow retail shops of recreational cannabis.

The province announced retailer hopefuls will have to follow a set of new mandates in order to be approved.

“Ontario will begin to consult on a number of rules all retailers will be mandated to follow including set hours of operation and staff training,” the province said.

This process will include conversations with Ontario municipalities, Indigenous communities, law enforcement, public health advocates, businesses and consumer groups as well as fellow province representatives.

Investor takeaway

Several cannabis companies have expressed interest in the retail landscape particularly with the province of Ontario. It will be key for investors to follow the performance of companies with retail aspirations during Tuesday’s (August 14) trading session.

One recent case of a cannabis company making a specific purchase for an entry into the retail space was Canopy Growth (TSX:WEED; NYSE:CGC) acquiring Hiku Brands (CSE:HIKU).

On Monday the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ), which holds close to 40 cannabis stocks, closed the day with a 3.41 percent decline and a price of C$15.28.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Hiku Brands is a client of the Investing News Network. This article is not paid-for content.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less